| 000 | 01864 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250516193811.0 | ||
| 264 | 0 | _c20150331 | |
| 008 | 201503s 0 0 eng d | ||
| 022 | _a1523-5866 | ||
| 024 | 7 |
_a10.1093/neuonc/not320 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCefalo, Graziella | |
| 245 | 0 | 0 |
_aTemozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial. _h[electronic resource] |
| 260 |
_bNeuro-oncology _cMay 2014 |
||
| 300 |
_a748-53 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadverse effects |
| 650 | 0 | 4 |
_aCerebellar Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aDacarbazine _xadverse effects |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aItaly |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMedulloblastoma _xdrug therapy |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 |
_aNeuroectodermal Tumors, Primitive _xdrug therapy |
| 650 | 0 | 4 | _aTemozolomide |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMassimino, Maura | |
| 700 | 1 | _aRuggiero, Antonio | |
| 700 | 1 | _aBarone, Giuseppe | |
| 700 | 1 | _aRidola, Vita | |
| 700 | 1 | _aSpreafico, Filippo | |
| 700 | 1 | _aPotepan, Paolo | |
| 700 | 1 | _aAbate, Massimo E | |
| 700 | 1 | _aMascarin, Maurizio | |
| 700 | 1 | _aGarrè, Maria Luisa | |
| 700 | 1 | _aPerilongo, Giorgio | |
| 700 | 1 | _aMadon, Enrico | |
| 700 | 1 | _aColosimo, Cesare | |
| 700 | 1 | _aRiccardi, Riccardo | |
| 773 | 0 |
_tNeuro-oncology _gvol. 16 _gno. 5 _gp. 748-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/neuonc/not320 _zAvailable from publisher's website |
| 999 |
_c23502984 _d23502984 |
||